• A randomized, placebo-controlled, 2-arm parallel-group superiority phase II study of GLYCOpyrrolate for moderate-to-severe sialorrhea in PARkinson’s disease - GLYCOPAR.   ROLE: Principal Investigator (2014) 

• Use of high resolution isotropic/three dimensional magnetic resonance imaging as a biomarker for the early distinction of Parkinson’s Disease from Atypical Parkinsonian Disorders.  ROLE: Principal Investigator (2014) 

• Lessebo effect in Parkinson’s disease. ROLE: Principal Investigator (2010 – current) 

• Clinical significant changes in advanced Parkinson’s disease patients using the intravenous levodopa model. ROLE: Principal Investigator (2010 – current) 

• Intravenous levodopa as a means of assessing severity of dyskinesia and duration of wearing-off in Parkinson’s disease patients. Clinimetric properties of commonly used dyskinesia rating scales. ROLE: Co-Investigator. (2010 – current)

• Biomarkers of PD risk in LRRK2 mutation carriers. ROLE: Co-investigator (2012 – current)

• Biomarkers in Huntington’s Disease - Systematic review on the topic and definition of guidelines for validation of biomarkers in Huntington’s disease. ROLE: Principal investigator (2012 – current)